Coloplast A/S Current Assets
The Current Assets of Coloplast A/S (COLO B.CO) as of Oct 10, 2026 is 10.45 B DKK. In the previous year, Current Assets was 10.95 B DKK — a change of -4.56% (lower).
Get this data via API
Financial Data API
Current Assets
10.45 BDKK
YoY
-4.56%
Last updated:
The Coloplast A/S Current Assets history
3 Years
10 Years
25 Years
Max
| YEAR | Current Assets | YoY |
|---|---|---|
| 10.45 BDKK | -4.56% | |
| 10.95 BDKK | +1.96% | |
| 10.74 BDKK | +13.18% | |
| 9.49 BDKK | +26.51% | |
| 7.50 BDKK | +6.13% | |
| 7.07 BDKK | +4.16% | |
| 6.79 BDKK | +17.06% | |
| 5.80 BDKK | -10.72% | |
| 6.49 BDKK | -0.29% | |
| 6.51 BDKK | +97.48% | |
| 3.30 BDKK | -14.05% | |
| 3.84 BDKK | +12.99% | |
| 3.40 BDKK | -9.80% | |
| 3.77 BDKK | +29.69% | |
| 2.90 BDKK | -13.42% | |
| 3.35 BDKK | -0.47% | |
| 3.37 BDKK | +125.35% | |
| 1.50 BDKK | -51.99% | |
| 3.11 BDKK | +8.73% | |
| 2.86 BDKK | -9.45% | |
| 3.16 BDKK | +4.43% | |
| 3.03 BDKK | -6.81% | |
| 3.25 BDKK | +199.27% | |
| 1.09 BDKK | — |
Coloplast A/S Stock analysis
Frequently Asked Questions about Coloplast A/S stock
Current Assets of Coloplast A/S is 10.45 B DKK in 2025.
Current Assets of Coloplast A/S changed from 10.95 B DKK to 10.45 B DKK, representing a -4.56% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Assets Coloplast A/S since 2006 – with annual values, charts, and detailed analysis.
Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.
Current Assets's DKK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Coloplast A/S historically and in real time.
Balance Sheet — Coloplast A/S
All Key Metrics — Coloplast A/S
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth